BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8002215)

  • 1. Near-diploid transitional cell carcinoma: a preliminary report.
    Chow NH; Tzai TS; Lin SN; Su WC; Cheng HL
    Int Urol Nephrol; 1994; 26(4):423-30. PubMed ID: 8002215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral heterogeneity of DNA indexes in transitional cell bladder cancer: relation to tumor histology.
    Lipponen PK; Eskelinen MJ; Nordling S
    Eur Urol; 1991; 20(4):311-4. PubMed ID: 1814748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
    Sun X
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-Flow cytometric analysis of bladder TCC using paraffin-embedded tissues.
    Wu L; Lochhead A; Yang J; Ow KT; Russell PJ
    Urol Int; 1998 Aug; 60(4):208-15. PubMed ID: 9701732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladder.
    Lipponen P; Eskelinen M; Syrjänen S; Tervahauta A; Syrjänen K
    Eur Urol; 1991; 20(3):238-42. PubMed ID: 1688050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy.
    Têtu B; Katz RL; Kalter SP; von Eschenbach AC; Barlogie B
    Cancer; 1987 Oct; 60(8):1815-22. PubMed ID: 3652008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA aberrations of bladder mucosa in patients with transitional cell carcinomas.
    Høstmark JG; Laerum OD; Farsund T
    Scand J Urol Nephrol; 1984; 18(2):113-20. PubMed ID: 6463594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders.
    Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E
    Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy.
    Lipponen PK; Eskelinen MJ; Nordling S
    Eur J Cancer; 1991; 27(7):877-81. PubMed ID: 1834120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image analysis confirmation of DNA aneuploidy in flow cytometric DNA distributions having a wide coefficient of variation of the G0/G1 peak.
    McFadden PW; Clowry LJ; Daehnert K; Hause LL; Koethe SM
    Am J Clin Pathol; 1990 May; 93(5):637-42. PubMed ID: 2327365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of cellular DNA content by flow cytometry in primary bladder carcinomas. Significance of monoclonal and multiclonal varieties of DNA aneuploidy.
    Campanella R; Russo A; Plaja S; Bazan V; Pavone C; Corselli G; Pavone-Macaluso M
    Eur Urol; 1992; 21(1):58-63. PubMed ID: 1606985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.
    Blomjous CE; Schipper NW; Baak JP; van Galen EM; de Voogt HJ; Meyer CJ
    J Clin Pathol; 1988 Jan; 41(1):21-5. PubMed ID: 3343376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oncogene ras P 21 expression and DNA ploidy in human bladder tumor].
    Wang Z
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):245-8. PubMed ID: 1806342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder.
    Tizzani A; Casetta G; Gontero P; Giammò A; Ghabin H; Demurtas S; Pacchioni D
    Minerva Urol Nefrol; 1997 Sep; 49(3):141-3. PubMed ID: 9396221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of the biological role of epidermal growth factor receptor in transitional cell carcinoma.
    Chow NH; Tzai TS; Lin SN; Chan SH; Tang MJ
    Eur Urol; 1993; 24(1):140-3. PubMed ID: 8365434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of deparaffinized nuclei in urinary bladder carcinoma. Comparison with cytogenetic analysis.
    Coon JS; Schwartz D; Summers JL; Miller AW; Weinstein RS
    Cancer; 1986 Apr; 57(8):1594-601. PubMed ID: 3948130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.